Skip to main content
Spexis AG logo

Spexis AG — Investor Relations & Filings

Ticker · SPEX ISIN · CH0106213793 LEI · 391200S8HJE1I96FIG04 SW Manufacturing
Open in API
Filings indexed 194 across all filing types
Latest filing 2022-07-20 Report Publication Anno…
Country CH Switzerland
Listing SW SPEX

About Spexis AG

https://www.polyphor.com/

Spexis AG is a clinical-stage biopharmaceutical company focused on discovering and developing therapeutics for rare diseases and oncology. The company leverages its expertise in macrocycle technology to create novel drug candidates designed to address high unmet medical needs. Its pipeline is advanced through a strategy that includes in-house discovery, development, in-licensing, and the acquisition of promising molecules. The primary therapeutic areas of interest include rare diseases and cancer, with an additional focus on antimicrobial resistance.

Recent filings

Filing Released Lang Actions
Spexis announces business update call to be held on July 28th
Report Publication Announcement Classification · 99% confidence The document is a news release from Spexis AG announcing a 'business update call' scheduled for July 28, 2022. It provides dial-in numbers, confirmation codes, and webcast links for participation. This content is characteristic of an announcement related to an upcoming event where financial or operational updates will be discussed, which strongly aligns with the definition of a Call Transcript (CT) if the transcript were present, or an announcement leading up to it. Since the document itself is the announcement *of* the call, and not the transcript itself, it is not a CT. It is also not an Earnings Release (ER) as it is a 'business update call,' not explicitly an earnings announcement. Given the focus on scheduling a call for updates, it is most closely related to the context of a conference call. However, none of the provided codes perfectly fit a 'Call Announcement.' The closest related category is 'Call Transcript' (CT), but this document is the *invitation* to the call. Since it is a specific announcement about a corporate event involving communication with investors/analysts, and it is not a standard regulatory filing like 10-K or IR, it falls best under the general category of investor communication. If the call were an earnings call, it would be related to ER. Since it is a general 'business update call,' and the document is short and announces an event rather than containing detailed financial results or a full transcript, it functions as a general corporate announcement. Given the options, and recognizing that this is an announcement *about* a call, it is often grouped with CTs or ERs in broader systems. However, based strictly on the definitions, it is an announcement of a future event. If we must choose the most relevant category based on the *subject matter* (a call), CT is the closest thematic fit, but the 'Menu vs Meal' rule suggests looking for RPA/RNS if it's just an announcement. Since this is a specific announcement about a call, and not just a generic 'report is attached' notice, I will evaluate if it fits better as a Call Transcript (CT) or a Regulatory Filing (RNS). Because it is an announcement *of* a call, and not the transcript itself, it is not CT. It is a specific corporate announcement, making RNS the most appropriate fallback if no other category fits. However, if the system expects announcements about calls to map to CT, that might be intended. Given the strong focus on the call details, and lacking a specific 'Call Announcement' code, I will classify it as RNS as it is a general corporate news item announcing an event, fitting the fallback definition better than the specific report types. Re-evaluating: The document is a press release announcing a conference call. This is a common type of filing. It is not a 10-K, AR, ER, or IR. It is not a DIV, DIRS, or MANG. It is an announcement of a future event. This type of announcement is often classified under RNS (Regulatory Filings/Miscellaneous Announcements) when a more specific code like 'Call Announcement' is missing. I will use RNS.
2022-07-20 English
Spexis announces business update call to be held on July 28th
Report Publication Announcement Classification · 99% confidence The document is a press release dated July 20, 2022, announcing that Spexis AG will hold a 'business update call' on July 28, 2022. It provides dial-in numbers, confirmation codes, and webcast links for this upcoming event. This content is an announcement about a scheduled conference call, not the transcript of the call itself, nor is it a formal regulatory filing like a 10-K or ER. The closest fit among the provided definitions is 'Call Transcript' (CT), but since this is the *announcement* of the call, and not the transcript, it functions as a general corporate communication regarding an event. Given the options, and recognizing that this is an announcement about an upcoming event where discussion will occur, it is most closely related to the context of a conference call. However, the document itself is an announcement of the call details. If the document were the transcript, it would be CT. Since it is the announcement of the call, and it doesn't fit other specific categories (like ER, DIV, CAP), it falls under the general regulatory/corporate announcement category. Since the event is a 'business update call' which often includes financial highlights or strategy updates, it is similar to an Earnings Release (ER) announcement, but the primary focus here is scheduling the call itself. Given the options, and the nature of announcing a call where discussion happens, 'Call Transcript' (CT) is often used loosely for call-related announcements, but 'Regulatory Filings' (RNS) is the safest fallback for non-standard announcements. However, since the content is explicitly about scheduling a 'conference call', and 'CT' is defined as the 'Full text transcript of company conference calls', this document is the precursor. In many databases, announcements of calls are often grouped near CT or RNS. Given the specific nature of announcing a call, and lacking a specific 'Call Announcement' code, I will classify it as RNS as a general corporate announcement about an upcoming event, as it is not the transcript itself (CT) nor a formal financial release (ER). Re-evaluating: The document is a press release announcing a call. This is a common type of corporate communication. It is not a formal financial report (10-K, IR, ER). It is not a dividend notice (DIV) or management change (MANG). It is an announcement of a future event. This fits best under the general 'Regulatory Filings' (RNS) category as a miscellaneous corporate announcement, as it is not the transcript (CT).
2022-07-20 English
Spexis kündigt für den 28. Juli ein Update zur Geschäftsentwicklung an
Report Publication Announcement Classification · 99% confidence The document is a short press release dated July 20, 2022, announcing that Spexis AG will hold a conference call on July 28, 2022, to provide a 'Business and Strategy Update' ('Update zur Geschäftsentwicklung'). It provides dial-in numbers and webcast links for this upcoming event. Since the document itself is an announcement about a future event (a call/presentation) rather than the transcript of the call (CT) or the presentation material itself (IP), and it is very short (under 5,000 characters), it fits the definition of a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS). Given that it specifically announces a future investor event/update, RPA is a strong candidate, but since it is a general announcement about an upcoming event rather than the publication of a formal report, and it doesn't fit other specific categories like ER or DIV, the general 'Regulatory Filings' (RNS) category serves as a safe fallback for such announcements, although RPA is also highly relevant as it announces an event where information will be shared. However, since the content is purely an announcement of a future call, and not the call transcript or the presentation slides, RPA (Report Publication Announcement) is the most precise fit for announcing an upcoming investor event/update call, even if the term 'Report' is used loosely for 'Update'. If the call itself were attached, it would be CT. Since it's an announcement of the call, RPA is appropriate.
2022-07-20 German
Spexis' CXCR4 inhibitor balixafortide demonstrates synergistic efficacy in combination with docetaxel in a metastatic prostate cancer preclinical model
Regulatory Filings Classification · 99% confidence The document is a press release dated July 7, 2022, detailing preclinical research results for a drug candidate (balixafortide) in combination with docetaxel for metastatic prostate cancer. It includes quotes from management and collaborators, contact information, and standard disclaimers. This type of announcement, focusing on research updates and pipeline progress, is characteristic of a general corporate or investor relations communication. Since it is not a formal regulatory filing like a 10-K, a specific financial report (ER, IR), or a proxy statement, it falls best under the general category for corporate news releases that don't fit other specific codes. Given the options, 'Regulatory Filings' (RNS) is the most appropriate fallback for a general corporate news announcement that isn't explicitly defined elsewhere, although it functions more like an Investor Presentation component or a general update. However, since it is a news release announcing research findings, and not a formal financial report or a specific administrative filing, RNS serves as the best fit among the provided codes for non-standard corporate disclosures.
2022-07-07 English
Spexis' CXCR4 inhibitor balixafortide demonstrates synergistic efficacy in combination with docetaxel in a metastatic prostate cancer preclinical model
Regulatory Filings Classification · 100% confidence The document is a press release dated 07.07.2022 announcing research update results regarding the drug balixafortide in a preclinical model. It contains key financial/operational news but is not a formal regulatory filing like a 10-K, nor is it a full transcript (CT) or a formal earnings release (ER) which typically includes standardized quarterly figures. It is an announcement of new scientific/development information. Since it is a news release detailing operational/research progress, it fits best under the general 'Regulatory Filings' (RNS) category as a general corporate announcement, or potentially an 'Investor Presentation' (IP) if it were structured as slides, but given the format, RNS is the most appropriate general category for non-standardized corporate news updates that aren't explicitly covered by other codes like DIV, CAP, or ER.
2022-07-07 English
Spexis' CXCR4 Inhibitor Balixafortide zeigt synergistische Wirksamkeit in Kombination mit Docetaxel in einem präklinischen Modell für metastasierenden Prostatakrebs
Regulatory Filings Classification · 100% confidence The document is a press release dated 07.07.2022 from Spexis AG, detailing preclinical research results for their drug Balixafortide in combination with Docetaxel for prostate cancer. It discusses scientific findings, quotes management and researchers, and provides contact information for investors and media. This format is characteristic of an announcement intended for immediate public disclosure regarding company developments, often related to research or operational updates, but it is not a formal regulatory filing like a 10-K, a comprehensive quarterly report (IR), or a specific financial event announcement (like DIV or CAP). Since it is a general news release about research progress and strategy evaluation, and it doesn't fit the specific categories like Earnings Release (ER) or Management Discussion (MDA), the most appropriate general category for a non-standard, timely corporate announcement is Regulatory Filings (RNS), which serves as a fallback for miscellaneous regulatory/news disclosures not covered elsewhere.
2022-07-07 German

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.